United States Biotechnology & Medical Research

Nuvalent Inc (NUVL)

Track

Over the past 90 days, Nuvalent Inc. insiders have executed 45 transactions, all of which were sales totaling approximately $42.4 million. Key executives, including the CEO, CFO, and Chief Scientific Officer, have participated in these planned divestments. These transactions follow the company's recent earnings report, during which the stock price has risen 20.8%.
Ticker: NUVL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nuvalent Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 9 Jul 2026
Value US$31,272.82 | Price 219.01 | Shares 2,981 (-7.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-09 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
2,981 -7.5%
219.01
US$31,273 		2,981 -7.5% 219.01 US$31,273
2026-07-09 2026-07-09 PrS Proposed sale
Henry E. Pelish

Officer

Officer
23,189
59.21
US$3,442,336 		23,189 59.21 US$3,442,336
2026-07-08 2026-07-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
17,035 -9.6%
144.71
US$2,152,968 		17,035 -9.6% 144.71 US$2,152,968
2026-07-06 2026-07-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
11,430 -11.8%
123.58
US$1,412,519 		11,430 -11.8% 123.58 US$1,412,519
2026-07-06 2026-07-01 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
23,000 -28.4%
123.59
US$2,842,570 		23,000 -28.4% 123.59 US$2,842,570
2026-07-01 2026-07-01 PrS Proposed sale
2.3
Alexandra Balcom

Officer

Officer
22,860
123.53
US$2,823,896 		22,860 123.53 US$2,823,896
2026-07-01 2026-06-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
5,500 -8.6%
123.51
US$679,305 		5,500 -8.6% 123.51 US$679,305
2026-06-11 2026-06-09 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
20,000 -25.6%
122.81
US$2,456,200 		20,000 -25.6% 122.81 US$2,456,200
2026-06-11 2026-06-09 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
20,000 -25.6%
122.81
US$2,456,200 		20,000 -25.6% 122.81 US$2,456,200
2026-06-09 2026-06-09 PrS Proposed sale
2.3
Darlene Noci

Officer

Officer
48,500
122.81
US$5,956,285 		48,500 122.81 US$5,956,285
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
3,036 -0.9%
89.63
US$272,117 		3,036 -0.9% 89.63 US$272,117
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
14,469 -4.2%
88.79
US$1,284,703 		14,469 -4.2% 88.79 US$1,284,703
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
12,495 -3.5%
87.97
US$1,099,185 		12,495 -3.5% 87.97 US$1,099,185
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
3,036 -0.9%
89.63
US$272,117 		3,036 -0.9% 89.63 US$272,117
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
14,469 -4.2%
88.79
US$1,284,703 		14,469 -4.2% 88.79 US$1,284,703
2026-06-10 2026-06-08 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
12,495 -3.5%
87.97
US$1,099,185 		12,495 -3.5% 87.97 US$1,099,185
2026-06-08 2026-06-08 PrS Proposed sale
James Richard Porter

Officer

Officer
90,000
90.48
US$8,143,200 		90,000 90.48 US$8,143,200
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
200 -0.2%
103.84
US$20,768 		200 -0.2% 103.84 US$20,768
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
279 -0.3%
101.79
US$28,399 		279 -0.3% 101.79 US$28,399
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
2,588 -2.9%
100.65
US$260,482 		2,588 -2.9% 100.65 US$260,482
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
3,133 -3.4%
99.86
US$312,861 		3,133 -3.4% 99.86 US$312,861
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,200 -1.3%
98.57
US$118,284 		1,200 -1.3% 98.57 US$118,284
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
900 -1.0%
97.68
US$87,912 		900 -1.0% 97.68 US$87,912
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
2,170 -2.3%
95.99
US$208,298 		2,170 -2.3% 95.99 US$208,298
2026-06-03 2026-06-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
960 -1.0%
94.87
US$91,075 		960 -1.0% 94.87 US$91,075
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,669 -2.7%
109.30
US$182,422 		1,669 -2.7% 109.30 US$182,422
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
900 -1.4%
108.14
US$97,326 		900 -1.4% 108.14 US$97,326
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,530 -2.4%
107.45
US$164,398 		1,530 -2.4% 107.45 US$164,398
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,401 -2.2%
106.32
US$148,954 		1,401 -2.2% 106.32 US$148,954
2026-06-01 2026-05-28 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,401 -2.2%
106.32
US$148,954 		1,401 -2.2% 106.32 US$148,954
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
100 -0.2%
109.76
US$10,976 		100 -0.2% 109.76 US$10,976
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
100 -0.2%
109.76
US$10,976 		100 -0.2% 109.76 US$10,976
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,500 -2.5%
109.30
US$163,950 		1,500 -2.5% 109.30 US$163,950
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,500 -2.5%
109.30
US$163,950 		1,500 -2.5% 109.30 US$163,950
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,178 -1.9%
108.01
US$127,236 		1,178 -1.9% 108.01 US$127,236
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,178 -1.9%
108.01
US$127,236 		1,178 -1.9% 108.01 US$127,236
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,422 -2.3%
107.33
US$152,623 		1,422 -2.3% 107.33 US$152,623
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,422 -2.3%
107.33
US$152,623 		1,422 -2.3% 107.33 US$152,623
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,300 -2.0%
106.26
US$138,138 		1,300 -2.0% 106.26 US$138,138
2026-06-01 2026-05-28 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
1,300 -2.0%
106.26
US$138,138 		1,300 -2.0% 106.26 US$138,138
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
2,111 -0.6%
102.88
US$217,180 		2,111 -0.6% 102.88 US$217,180
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
17,353 -5.0%
102.10
US$1,771,741 		17,353 -5.0% 102.10 US$1,771,741
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
7,429 -2.1%
101.48
US$753,895 		7,429 -2.1% 101.48 US$753,895
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,408 -0.4%
99.77
US$140,476 		1,408 -0.4% 99.77 US$140,476
2026-05-06 2026-05-04 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
1,699 -0.5%
98.54
US$167,419 		1,699 -0.5% 98.54 US$167,419
2026-05-05 2026-05-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
124 -0.1%
99.97
US$12,396 		124 -0.1% 99.97 US$12,396
2026-05-05 2026-05-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
7,434 -8.0%
99.29
US$738,122 		7,434 -8.0% 99.29 US$738,122
2026-05-05 2026-05-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
3,872 -4.0%
98.42
US$381,082 		3,872 -4.0% 98.42 US$381,082
2026-05-01 2026-04-30 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,082 -1.8%
99.57
US$107,735 		1,082 -1.8% 99.57 US$107,735
2026-05-01 2026-04-30 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
4,418 -6.8%
99.13
US$437,956 		4,418 -6.8% 99.13 US$437,956
2026-04-30 2026-04-30 PrS Proposed sale
2.6
DEBORAH MILLER

Officer

Officer
16,500
99.10
US$1,635,150 		16,500 99.10 US$1,635,150
2026-05-01 2026-04-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
300 -0.5%
101.17
US$30,351 		300 -0.5% 101.17 US$30,351
2026-05-01 2026-04-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
700 -1.2%
100.14
US$70,098 		700 -1.2% 100.14 US$70,098
2026-05-01 2026-04-29 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
4,500 -7.1%
99.35
US$447,075 		4,500 -7.1% 99.35 US$447,075
2026-04-13 2026-04-09 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
900 -1.4%
105.00
US$94,500 		900 -1.4% 105.00 US$94,500
2026-04-13 2026-04-09 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
2,193 -3.2%
104.27
US$228,664 		2,193 -3.2% 104.27 US$228,664
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
100 -0.0%
105.60
US$10,560 		100 -0.0% 105.60 US$10,560
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
6,121 -1.8%
104.78
US$641,358 		6,121 -1.8% 104.78 US$641,358
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
12,425 -3.6%
103.78
US$1,289,466 		12,425 -3.6% 103.78 US$1,289,466
2026-04-08 2026-04-06 PlS Planned sale
Porter James Richard

President and CEO

Executive Director
11,354 -3.2%
103.21
US$1,171,846 		11,354 -3.2% 103.21 US$1,171,846
2026-04-03 2026-04-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
2,469 -2.8%
106.18
US$262,158 		2,469 -2.8% 106.18 US$262,158
2026-04-03 2026-04-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
5,417 -5.8%
105.30
US$570,410 		5,417 -5.8% 105.30 US$570,410
2026-04-03 2026-04-01 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
3,544 -3.7%
104.39
US$369,958 		3,544 -3.7% 104.39 US$369,958
2026-04-01 2026-03-30 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
2,968 -4.9%
98.13
US$291,250 		2,968 -4.9% 98.13 US$291,250
2026-04-01 2026-03-30 PlS Planned sale
2.3
Noci Darlene

Chief Development Officer

Officer
2,532 -4.0%
97.43
US$246,693 		2,532 -4.0% 97.43 US$246,693
2026-03-30 2026-03-30 PrS Proposed sale
2.3
Darlene Noci

Officer

Officer
22,000
96.66
US$2,126,520 		22,000 96.66 US$2,126,520
2026-03-30 2026-03-26 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
2,803 -4.5%
99.46
US$278,786 		2,803 -4.5% 99.46 US$278,786
2026-03-30 2026-03-26 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
1,757 -2.7%
98.21
US$172,555 		1,757 -2.7% 98.21 US$172,555
2026-03-30 2026-03-26 PlS Planned sale
2.6
Miller Deborah Ann

Chief Legal Officer

Officer
940 -1.4%
97.50
US$91,650 		940 -1.4% 97.50 US$91,650
2026-03-26 2026-03-25 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
13,700 -13.8%
100.16
US$1,372,192 		13,700 -13.8% 100.16 US$1,372,192
2026-03-26 2026-03-24 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
1,160 -1.2%
96.50
US$111,940 		1,160 -1.2% 96.50 US$111,940
2026-03-26 2026-03-24 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
7,671 -7.1%
95.88
US$735,495 		7,671 -7.1% 95.88 US$735,495
2026-03-26 2026-03-24 PlS Planned sale
2.3
Balcom Alexandra

Chief Financial Officer

Officer
2,599 -2.3%
95.03
US$246,983 		2,599 -2.3% 95.03 US$246,983
2026-03-24 2026-03-24 PrS Proposed sale
2.3
Alexandra Balcom

Officer

Officer
59,420
96.43
US$5,729,870 		59,420 96.43 US$5,729,870
2026-03-16 2026-03-13 PlS Planned sale
Pelish Henry E.

Chief Scientific Officer

Officer
1,703 -2.5%
99.71
US$169,806 		1,703 -2.5% 99.71 US$169,806
Explore more

More insider trading research around Nuvalent Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America